Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma is the most common liver malignancy. In the population with an advanced stage of the disease, outcomes could be disappointed by treating with molecular targeting agents because of low treatment response rates. It has gained improving effects of immune checkpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Hao-Chien, Lee, Jin-Chiao, Wang, Yu-Chao, Cheng, Chih-Hsien, Wu, Tsung-Han, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Chan, Kun-Ming, Lee, Wei-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036568/
https://www.ncbi.nlm.nih.gov/pubmed/33807219
http://dx.doi.org/10.3390/cancers13071607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036568/
https://www.ncbi.nlm.nih.gov/pubmed/33807219
http://dx.doi.org/10.3390/cancers13071607

Ejemplares similares